Adaptive Biotechnologies Corp ($ADPT)
Filing Information
| Accession Number | 0001780664-26-000035 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 6, 2026 |
| Document | View SEC Filing |
Transactions
11
Total Shares
106,929
Total Value
$1,447,034.84
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President and COO | Common Stock | โ | Oct 1, 2026 | Exercise/Conversion | 11,881 | $12.14 | $144,235.34 | 389,683 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Oct 1, 2026 | Sale | 6,081 | $27.57 | $167,653.17 | 383,602 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Oct 1, 2026 | Sale | 5,800 | $28.56 | $165,648.00 | 377,802 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Oct 2, 2026 | Exercise/Conversion | 11,881 | $12.14 | $144,235.34 | 389,683 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Oct 2, 2026 | Sale | 11,881 | $28.13 | $334,212.53 | 377,802 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Oct 5, 2026 | Exercise/Conversion | 11,881 | $12.14 | $144,235.34 | 389,683 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Oct 5, 2026 | Sale | 6,699 | $28.82 | $193,065.18 | 382,984 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Oct 5, 2026 | Sale | 5,182 | $29.67 | $153,749.94 | 377,802 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Oct 1, 2026 | Exercise/Conversion | 11,881 | $0.00 | $0.00 | 367,896 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Oct 2, 2026 | Exercise/Conversion | 11,881 | $0.00 | $0.00 | 356,015 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Oct 5, 2026 | Exercise/Conversion | 11,881 | $0.00 | $0.00 | 344,134 | Direct | โ | View Details |